Code of Virginia
Chapter 34 - Drug Control Act
§ 54.1-3448. Schedule II

The controlled substances listed in this section are included in Schedule II:
1. Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:
Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene, naloxone naltrexone and their respective salts, but including the following:
Raw opium;
Opium extracts;
Opium fluid extracts;
Powdered opium;
Granulated opium;
Tincture of opium;
Codeine;
Dihydroetorphine;
Ethylmorphine;
Etorphine hydrochloride;
Hydrocodone;
Hydromorphone;
Metopon;
Oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-4, 5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol);
Morphine;
Noroxymorphone;
Oxycodone;
Oxymorphone;
Thebaine.
Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in this subdivision, but not including the isoquinoline alkaloids of opium.
Opium poppy and poppy straw.
Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine; cocaine or any salt or isomer thereof.
Concentrate of poppy straw, the crude extract of poppy straw in either liquid, solid or powder form, which contains the phenanthrene alkaloids of the opium poppy.
2. Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:
Alfentanil;
Alphaprodine;
Anileridine;
Bezitramide;
Bulk dextropropoxyphene (nondosage forms);
Carfentanil;
Dihydrocodeine;
Diphenoxylate;
Fentanyl;
Isomethadone;
Levo-alphacetylmethadol (levo-alpha-acetylmethadol)(levomethadyl acetate)(LAAM);
Levomethorphan;
Levorphanol;
Metazocine;
Methadone;
Methadone — Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
Moramide — Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylicacid;
Pethidine (other name: meperidine);
Pethidine — Intermediate — A, 4-cyano-1-methyl-4-phenylpiperidine;
Pethidine — Intermediate — B, ethyl-4-phenylpiperidine-4-carboxylate;
Pethidine — Intermediate — C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
Phenazocine;
Piminodine;
Racemethorphan;
Racemorphan;
Remifentanil;
Sufentanil;
Tapentadol;
Thiafentanil.
3. Any material, compound, mixture or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
Amphetamine, its salts, optical isomers, and salts of its optical isomers;
Phenmetrazine and its salts;
Any substance which contains any quantity of methamphetamine, including its salts, isomers, and salts of isomers;
Methylphenidate;
Lisdexamfetamine, its salts, isomers, and salts of its isomers.
4. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
Amobarbital;
Glutethimide;
Secobarbital;
Pentobarbital;
Phencyclidine.
5. The following hallucinogenic substances:
Nabilone;
Dronabinol ((-)-delta-9-trans tetrahydrocannabinol) in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration.
6. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances which are:
a. Immediate precursors to amphetamine and methamphetamine:
Phenylacetone.
b. Immediate precursor to phencyclidine:
1-phenylcyclohexylamine;
1-piperidinocyclohexanecarbonitrile (other name: PCC).
c. Immediate precursor to fentanyl:
4-anilino-N-phenethyl-4-piperidine (ANPP).
1972, c. 798, § 54-524.84:6; 1976, c. 614; 1977, c. 302; 1978, c. 833; 1979, c. 387; 1981, c. 30; 1984, c. 192; 1986, c. 463; 1988, cc. 283, 765; 1992, c. 737; 1994, c. 763; 1998, c. 105; 2000, c. 135; 2005, c. 119; 2008, c. 74; 2010, c. 423; 2011, c. 700; 2017, c. 612; 2019, c. 85; 2022, cc. 114, 115.

Structure Code of Virginia

Code of Virginia

Title 54.1 - Professions and Occupations

Chapter 34 - Drug Control Act

§ 54.1-3400. Citation

§ 54.1-3401. Definitions

§ 54.1-3401.1. Repealed

§ 54.1-3402. Repealed

§ 54.1-3403. Chapter not applicable to economic poisons

§ 54.1-3404. Inventories of controlled substances required of certain persons; contents and form of record

§ 54.1-3405. Access to and copies of records; inspections

§ 54.1-3406. Records confidential; disclosure of information about violations of federal law

§ 54.1-3407. Analysis of controlled substances

§ 54.1-3408. Professional use by practitioners

§ 54.1-3408.01. Requirements for prescriptions

§ 54.1-3408.02. Transmission of prescriptions

§ 54.1-3408.03. Dispensing of therapeutically equivalent drug product permitted

§ 54.1-3408.04. Dispensing of interchangeable biosimilars permitted

§ 54.1-3408.05. Use of FDA-approved substance upon publication of final rule

§ 54.1-3408.1. Prescription in excess of recommended dosage in certain cases

§ 54.1-3408.2. Failure to report administration or dispensing of or prescription for controlled substances; report required; penalty

§ 54.1-3408.3. Certification for use of cannabis oil for treatment

§ 54.1-3408.4. Expired

§ 54.1-3408.5. Epinephrine required in certain public places

§ 54.1-3409. Professional use by veterinarians

§ 54.1-3410. When pharmacist may sell and dispense drugs

§ 54.1-3410.1. Requirements for radiopharmaceuticals

§ 54.1-3410.2. Compounding; pharmacists' authority to compound under certain conditions; labeling and record maintenance requirements

§ 54.1-3411. When prescriptions may be refilled

§ 54.1-3411.1. Prohibition on returns, exchanges, or re-dispensing of drugs; exceptions

§ 54.1-3411.2. Prescription drug disposal programs

§ 54.1-3411.2:1. Guidelines for disposal of unused drugs

§ 54.1-3412. Date of dispensing; initials of pharmacist; automated data processing system

§ 54.1-3413. Manufacturing and administering Schedule I drugs

§ 54.1-3414. Official orders for Schedule II drugs

§ 54.1-3415. Distribution of drugs in Schedules II through VI by manufacturers and wholesalers

§ 54.1-3415.1. Delivery of medical devices on behalf of a medical equipment supplier

§ 54.1-3416. No prescription for preparations listed pursuant to Schedule V

§ 54.1-3417. Disposing of stocks of Schedules II through V drugs

§ 54.1-3418. Sale of aqueous or oleaginous solutions

§ 54.1-3419. Dispensing of insulin preparations

§ 54.1-3420. Distribution of certain drugs; written request or confirmation of receipt

§ 54.1-3420.1. Identification required for filling prescriptions

§ 54.1-3420.2. Delivery of prescription drug order

§ 54.1-3421. New drugs

§ 54.1-3422. Controlled substances registration certificate required in addition to other requirements; exemptions

§ 54.1-3423. Board to issue registration unless inconsistent with public interest; authorization to conduct research; application and fees

§ 54.1-3424. Suspension or revocation of registration, license or permit; limitation to particular controlled substance; controlled substances placed under seal; sale of perishables and forfeiture; notification to DEA

§ 54.1-3425. Repealed

§ 54.1-3426. Regulations for special packaging

§ 54.1-3427. Dispensing drugs without safety closure container

§ 54.1-3428. Dissemination of information

§ 54.1-3429. Revocation of permit issued to manufacturer, wholesaler or distributor

§ 54.1-3430. Display of permit; permits nontransferable; renewal

§ 54.1-3431. Admission into evidence of certain certificates of analysis

§ 54.1-3432. Supervision by pharmacist

§ 54.1-3433. Certain advertising and signs unlawful

§ 54.1-3434. Permit to conduct pharmacy

§ 54.1-3434.01. Notice of pharmacy closing; change of ownership; penalty

§ 54.1-3434.02. Automated drug dispensing systems

§ 54.1-3434.03. Continuous quality improvement program

§ 54.1-3434.04. Automatic review of certain case decisions

§ 54.1-3434.05. Permit to act as an outsourcing facility

§ 54.1-3434.1. Nonresident pharmacies to register with Board

§ 54.1-3434.2. Permit to be issued

§ 54.1-3434.3. Denial, revocation, suspension of registration, summary proceedings

§ 54.1-3434.4. Prohibited acts

§ 54.1-3434.5. Nonresident outsourcing facilities to register with the Board

§ 54.1-3435. License to act as wholesale distributor; renewal; fee

§ 54.1-3435.01. Registration of nonresident wholesale distributors; renewal; fee

§ 54.1-3435.02. Certain permitted pharmacies and medical equipment suppliers exempted

§ 54.1-3435.1. Denial, revocation, and suspension of license, permit, or registration of certain entities

§ 54.1-3435.2. Permit to act as medical equipment supplier; storage; limitation; regulations

§ 54.1-3435.3. Inspection and audit

§ 54.1-3435.3:1. Registration of nonresident medical equipment suppliers; renewal; fee

§ 54.1-3435.4. Permit to act as warehouser; regulations

§ 54.1-3435.4:01. Registration to act as a nonresident warehouser; regulations

§ 54.1-3435.4:1. Permitting of third-party logistics provider; renewal

§ 54.1-3435.4:2. Registration of nonresident third-party logistics provider; renewal

§ 54.1-3435.5. Repealed

§ 54.1-3436. Repealed

§ 54.1-3436.1. Prescription drug price transparency

§ 54.1-3437. Permit to manufacture drugs

§ 54.1-3437.1. Limited permit for repackaging drugs

§ 54.1-3438. Manufacturing, etc., of drugs or proprietary medicines, to be supervised by pharmacist

§ 54.1-3439. Application for nonrestricted manufacturing permit; fee

§ 54.1-3440. Persons to whom nonrestricted permit is granted

§ 54.1-3441. Restricted manufacturing permit; application; fee; separate application and permit for each place of manufacturing

§ 54.1-3442. When permit not to be granted; regulations

§ 54.1-3442.01. Registration of nonresident manufacturer; renewal

§ 54.1-3442.02. Prescription drug price transparency

§ 54.1-3442.1. Definitions

§ 54.1-3442.2. Eligibility for expanded access to investigational drugs, biological products, and devices; written, informed consent to treatment

§ 54.1-3442.3. Expanded access to investigational drugs, biological products, or devices; cost; insurance coverage

§ 54.1-3442.4. Limitation of liability

§ 54.1-3442.5. Definitions

§ 54.1-3442.6. Permit to operate pharmaceutical processor or cannabis dispensing facility

§ 54.1-3442.7. Dispensing cannabis products; report

§ 54.1-3442.8. Criminal liability; exceptions

§ 54.1-3443. Board to administer article

§ 54.1-3444. Controlled substances included by whatever name designated

§ 54.1-3445. Placement of substance in Schedule I

§ 54.1-3446. Schedule I

§ 54.1-3447. Placement of substance in Schedule II

§ 54.1-3448. Schedule II

§ 54.1-3449. Placement of substance in Schedule III

§ 54.1-3450. Schedule III

§ 54.1-3451. Placement of substance in Schedule IV

§ 54.1-3452. Schedule IV

§ 54.1-3453. Placement of substance in Schedule V

§ 54.1-3454. Schedule V

§ 54.1-3455. Schedule VI

§ 54.1-3456. Controlled substance analog

§ 54.1-3456.1. Drugs of concern

§ 54.1-3457. Prohibited acts

§ 54.1-3458. Violations

§ 54.1-3459. Tagging of adulterated or misbranded drugs, devices, or cosmetics; condemnation; destruction; expenses

§ 54.1-3460. Poisonous or deleterious substance, or color additive

§ 54.1-3461. Adulterated drug or device

§ 54.1-3462. Misbranded drug or device

§ 54.1-3463. Exemption of drugs dispensed by filling or refilling prescription

§ 54.1-3464. Adulterated cosmetics

§ 54.1-3465. Misbranded cosmetics

§ 54.1-3466. Possession or distribution of controlled paraphernalia; definition of controlled paraphernalia; evidence; exceptions

§ 54.1-3467. Distribution of hypodermic needles or syringes, gelatin capsules, quinine or any of its salts

§ 54.1-3468. Conditions to dispensing device, item, or substance; records

§ 54.1-3469. Storage, usage, and disposition of controlled paraphernalia

§ 54.1-3470. Obtaining controlled paraphernalia by fraud, etc.

§ 54.1-3471. Issuance of permits to certain persons other than registered pharmacists

§ 54.1-3472. Article inapplicable to certain persons